相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Epithelial-Mesenchymal Transition in Cancer: A Historical Overview
Domenico Ribatti et al.
TRANSLATIONAL ONCOLOGY (2020)
Emerging Mechanisms by which EMT Programs Control Stemness
Molly M. Wilson et al.
TRENDS IN CANCER (2020)
Expanding the Role of the Histone Lysine-Specific Demethylase LSD1 in Cancer
Barbara Majello et al.
CANCERS (2019)
Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
So-Yeon Park et al.
CANCERS (2019)
LSD1/KDM1A, a Gate-Keeper of Cancer Stemness and a Promising Therapeutic Target
Panagiotis Karakaidos et al.
CANCERS (2019)
PELP1 promotes glioblastoma progression by enhancing Wnt/β-catenin signaling
Gangadhara R. Sareddy et al.
NEURO-ONCOLOGY ADVANCES (2019)
ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia
Tamara Maes et al.
CANCER CELL (2018)
Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066
Cong-Cong Cheng et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Lysine-Specific Demethylase 1A as a Promising Target in Acute Myeloid Leukemia
Daniela Magliulo et al.
FRONTIERS IN ONCOLOGY (2018)
Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance
Sonia Palomeras et al.
MOLECULES (2018)
Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway
G. R. Sareddy et al.
ONCOGENE (2017)
Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells
Ran Ma et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
A novel LSD1 inhibitor NCD38 ameliorates MDS-related leukemia with complex karyotype by attenuating leukemia programs via activating super-enhancers
N. Sugino et al.
LEUKEMIA (2017)
A comprehensive review of lysine-specific demethylase 1 and its roles in cancer
Amir Hosseini et al.
EPIGENOMICS (2017)
Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells
Ran Ma et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Darshan S. Chandrashekar et al.
NEOPLASIA (2017)
Constitutive activation of STAT3 in breast cancer cells: A review
Kasturi Banerjee et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Biology and Management of Patients With Triple-Negative Breast Cancer
Priyanka Sharma
ONCOLOGIST (2016)
Methylation-dependent regulation of HIF-1 alpha stability restricts retinal and tumour angiogenesis
Yunho Kim et al.
NATURE COMMUNICATIONS (2016)
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
Brian D. Lehmann et al.
PLOS ONE (2016)
A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 inhibitors in SCLC
Helai P. Mohammad et al.
CANCER CELL (2015)
Triple negative breast cancer: looking for the missing link between biology and treatments
Giuseppe Palma et al.
ONCOTARGET (2015)
The fate of chemoresistance in triple negative breast cancer (TNBC)
Elma A. O'Reilly et al.
BBA CLINICAL (2015)
Enriched CD44+/CD24- population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC)
Fei Ma et al.
CANCER LETTERS (2014)
Expression of cancer stem cell markers in basal and penta-negative breast carcinomas - A study of a series of triple-negative tumors
Diego de Mendonca Uchoa et al.
PATHOLOGY RESEARCH AND PRACTICE (2014)
Lysine-Specific Demethylase 1-Selective Inactivators: Protein-Targeted Drug Delivery Mechanism
Daisuke Ogasawara et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity
Christine L. Chaffer et al.
CELL (2013)
Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells
Seog-Young Kim et al.
CELLULAR SIGNALLING (2013)
Histone lysine demethylases as targets for anticancer therapy
Jonas W. Hojfeldt et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
KDM1 is a novel therapeutic target for the treatment of gliomas
Gangadhara R. Sareddy et al.
ONCOTARGET (2013)
The Deubiquitinase USP28 Stabilizes LSD1 and Confers Stem-Cell-like Traits to Breast Cancer Cells
Yadi Wu et al.
CELL REPORTS (2013)
Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up
L. Malorni et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
CD44+/CD24-/low cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome
Michael O. Idowu et al.
HUMAN PATHOLOGY (2012)
Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer
Yasuyo Ohi et al.
HISTOPATHOLOGY (2011)
The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine-specific demethylase 1
Yiwei Lin et al.
EMBO JOURNAL (2010)
Lysine Methylation Regulates E2F1-Induced Cell Death
Haroula Kontaki et al.
MOLECULAR CELL (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes
Jinbo Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation
Jing Wang et al.
NATURE GENETICS (2009)
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
Chad J. Creighton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mechanisms involved in the regulation of histone lysine demethylases
Fei Lan et al.
CURRENT OPINION IN CELL BIOLOGY (2008)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
HER2 and response to paclitaxel in node-positive breast cancer
Daniel F. Hayes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
p53 is regulated by the lysine demethylase LSD1
Jing Huang et al.
NATURE (2007)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
分享论文
